Jun 07, 2021 / 02:00PM GMT
Henry Wheeler - AstraZeneca PLC - IR
So good morning, good afternoon, everyone, and welcome to AstraZeneca's ASCO 2021 Meet The Management Event. We're very pleased to have our oncology leadership team here. To start with, I'll hand over to Pascal to make some introductory remarks. Pascal, please ahead.
Pascal Soriot - AstraZeneca PLC - CEO & Executive Director
Thank you, Henry. And good morning, good afternoon, everybody. Thank you so much for your interest and for joining us today. As you will -- as you've seen at the ASCO this year, and you will hear more about it in the next few minutes, our company continues to make good progress. And in particular, the Oncology team is continuing to deliver greater results from a business viewpoint, but importantly from a pipeline viewpoint. We have some very strong data that have been presented and more to come.
The first quarter was a strong quarter as you saw and we continue to make good progress across the entire portfolio of products. But today the focus of course is on Oncology. And without further ado,
AstraZeneca PLC Meet AZN Management: Oncology - 2021 ASCO Annual Meeting Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers